Case Details
- Citation: [2016] SGHC 226
- Case Title: Public Prosecutor v Selamat bin Paki and others
- Court: High Court of the Republic of Singapore
- Decision Date: 20 October 2016
- Judge: Choo Han Teck J
- Coram: Choo Han Teck J
- Case Number: Criminal Case No 12 of 2015
- Plaintiff/Applicant: Public Prosecutor
- Defendants/Respondents: Selamat Bin Paki; Ali Bin Mohamad Bahashwan; Ragunath Nair A/L Janartanan
- Legal Area: Criminal Law — Statutory offences
- Statutory Framework: Misuse of Drugs Act (Cap 185, 2008 Rev Ed)
- Primary Charges (as summarised in the extract):
- Selamat: trafficking in a controlled drug (diamorphine) under s 5(1)(a), punishable under s 33(1)
- Ali: abetment by instigation of trafficking under s 5(1)(a) read with s 12, punishable under s 33(1)
- Ragunath: trafficking by delivering the drug to Selamat under s 5(1)(a), punishable under s 33(1)
- Key Factual Date: 23 October 2012
- Drug Quantity (as analysed): not less than 27.12g of diamorphine (net) in the “Bundle”
- Additional Quantity in Flat: 12.13g (net) of diamorphine (Ali admitted ownership; Selamat denied knowledge)
- Judgment Length: 7 pages, 4,385 words
- Counsel for Prosecution: Eugene Lee, Andrew Low, Lee Zu Zhao and Theong Li Han (Attorney-General’s Chambers)
- Counsel for First Accused: Luke Lee (Luke Lee & Co), Sanjiv Rajan and Cai Cheng Ying (Allen & Gledhill LLP); first accused also appeared in-person at certain stages
- Counsel for Second Accused: Ong Cheong Wei (Belinda Ang Tang & Partners), Cheong Jun Mervyn Mervyn (Eugene Thuraisingam); second accused also appeared in-person at certain stages; later Michael Chia Soo, Hany Soh Hui Bin (Chia Thomas Law Chambers LLC) and Sankar s/o Kailasa Thevar Saminathan (Sterling Law Corporation); later Ismail Hamid and others
- Counsel for Third Accused: K Jayakumar Naidu (Jay Associates) and Nedumaran Muthukrishnan (M Nedumaran & Co); third accused also appeared in-person at certain stages
- Related Appeal Note (editorial): Appeals to this decision in Criminal Appeals Nos 33, 34 and 35 of 2016 were dismissed by the Court of Appeal on 5 March 2018. See [2018] SGCA 13.
Summary
Public Prosecutor v Selamat bin Paki and others [2016] SGHC 226 is a High Court decision concerning trafficking in diamorphine (heroin) and the operation of statutory presumptions under Singapore’s Misuse of Drugs Act. Three men were charged arising from an exchange at the void deck of an HDB block in Tampines on 23 October 2012. The prosecution alleged that the first and third accused were involved in trafficking by transporting and delivering a drug “Bundle”, while the second accused abetted the trafficking by instigating the first accused to collect the drug and providing money for the transaction.
The central contest in the extract provided concerns the statutory presumption of trafficking under s 17(c) of the Misuse of Drugs Act. Although the accused were charged on the basis that the net diamorphine in the Bundle was not less than 27.12g, they attempted to rebut the presumption by arguing that only half of the Bundle was intended for sale, with the remainder for personal consumption. The court held that the accused failed to discharge the burden of proof on a balance of probabilities. In particular, the court found their evidence on consumption patterns and the “accounting” of intended sale was not credible or sufficiently proved.
What Were the Facts of This Case?
On 23 October 2012, Selamat and Ali met Ragunath at the void deck of Blk 299B Tampines Street 22. Ragunath delivered a packet containing 456.2g of a granular/powdery substance. Subsequent analysis showed that the packet contained not less than 27.12g of diamorphine (net). In return, Selamat handed Ragunath a packet of money containing $5,400. The accused’s narrative was that they did not know the exact amount of money in the packet and that Ali had instructed Selamat to hand over the money to the person delivering the Bundle.
Shortly after the exchange, all three men were arrested. They were subsequently charged with trafficking in diamorphine. Selamat was charged with transporting the Bundle from the void deck to the lift landing of the block, while Ragunath was charged with trafficking by delivering the drug to Selamat. Ali was charged not as a direct transporter or deliverer, but as an abettor by instigation: the charge alleged that Ali instigated Selamat to transport the Bundle and provided the money for the transaction.
Although the charges were framed around the Bundle’s net diamorphine content (27.12g), the prosecution’s evidence also included the existence of additional diamorphine in the flat where Selamat and Ali lived. The court noted that there was another 12.13g (net) of diamorphine in the Flat. Ali admitted ownership of those drugs, while Selamat denied knowledge of them. Both Selamat and Ali were drug addicts, and the court’s reasoning repeatedly returned to the plausibility of their claimed consumption and the economic logic of their alleged “half-for-sale, half-for-consumption” arrangement.
At trial, Selamat and Ali admitted that they consumed heroin and also trafficked. The extract indicates that Selamat initially denied knowledge of the contents of the Bundle but did not persist with that point by the end of the trial. The defence strategy, therefore, was not directed at denying the existence of trafficking activity in principle, but at reducing the quantity of diamorphine that should be treated as “for trafficking” for the purpose of the capital punishment threshold. Specifically, they argued that only half of the Bundle was intended for sale. On their calculations, half of 27.12g net would be 13.56g, which is below the 15g net threshold relevant to the statutory sentencing consequences.
What Were the Key Legal Issues?
The key legal issue was whether Selamat and Ali could rebut the statutory presumption of trafficking under s 17(c) of the Misuse of Drugs Act. Section 17(c) provides that where a person is proved to have had in possession more than 2g of diamorphine, the court shall presume that the person had the drug in possession for the purpose of trafficking, unless it is proved that the possession was not for that purpose. Because the presumption shifts the burden of proof to the accused, the question became whether the accused could prove, on a balance of probabilities, that their possession was not for trafficking in quantities exceeding the threshold relevant to the capital punishment regime.
Related to this was the evidential question of what “intended for sale” meant in the context of the presumption. The court had to assess whether the accused’s claim that only half the Bundle was for sale was sufficiently established by credible evidence. This required evaluation of their testimony about consumption rates, the reliability of expert evidence (including a report by Dr Winslow Rasaiah Munidasa), and the internal coherence of their “accounting” argument that they would otherwise incur a loss on the drug purchase.
Although the extract focuses primarily on Selamat and Ali, the overall case also involved the legal treatment of abetment by instigation under s 12 of the Misuse of Drugs Act read with s 5(1)(a). The court needed to determine whether Ali’s conduct—particularly instructing Selamat to collect the Bundle and providing money—amounted to instigation sufficient to establish liability for abetment of trafficking.
How Did the Court Analyse the Issues?
The court began by setting out the structure of proof in drug trafficking cases. In general, the prosecution must prove its case beyond a reasonable doubt. However, where the accused must prove a defence or rebut a presumption in law, the burden is discharged on a balance of probabilities. The court expressly identified s 17(c) as the operative presumption: once possession of more than 2g of diamorphine is proved, trafficking is presumed unless the accused proves otherwise. This meant that Selamat and Ali had to prove that their possession was not for trafficking in the relevant quantity sense.
In assessing whether the presumption was rebutted, the court scrutinised the accused’s evidence on consumption patterns and the claimed division of the Bundle between sale and personal use. The court found the accused’s statements about their rate of consumption to be “bare assertions” that did not amount to credible proof. Both accused were drug addicts, and their testimony about how much heroin they consumed daily was central to their argument that they needed only part of the Bundle for consumption. However, the court concluded that the evidence did not establish a reliable consumption pattern.
The court also evaluated the expert report by Dr Winslow, who had opined that the accused were heavy consumers based on reported consumption patterns and observed withdrawal symptoms post-arrest. The court rejected the report as a basis for proving the consumption rate relevant to the defence. It noted that Dr Winslow’s findings were mainly based on the accused’s uncorroborated evidence, and that under cross-examination Dr Winslow conceded this limitation. Further, the court held that withdrawal symptoms could not reliably establish the amount consumed because the correlation between dosage and withdrawal symptoms is general and may vary between individuals. This undermined the defence attempt to use expert evidence to convert subjective claims into objective proof.
Beyond consumption, the court analysed the economic plausibility of the defence’s “half-for-sale” calculation. The accused argued that half the Bundle was intended for sale and the other half for personal consumption. The court found an “accounting deficit” in this narrative: if half the net diamorphine was sold, the revenue would be less than the cost of purchasing the heroin. Using the accused’s own figures, the court reasoned that a pound of heroin (27.12g net) could be repacked into 58 smaller packets of 8.4g gross weight and sold at $180 per packet. If only half the Bundle were sold, the number of packets sold would yield revenue of $5,220, which is less than the $5,400 purchase price. Ali admitted this loss but claimed he could “roll over the money” without explaining how. The court treated this as insufficient to make the defence credible.
Importantly, the court drew an inference from the broader context: both men were drug abusers who paid for their drug use by selling drugs themselves. If they were consistently selling at a loss, the court reasoned, they would lack the means to fund their consumption. While the court acknowledged that the accused’s calculations could be imperfect due to imperfect recollection and lack of strict accounting, it held that the law requires more than circumstances that might create doubt. The presumption required proof on a balance of probabilities that the possession was not for trafficking beyond the relevant threshold. The accused did not meet that standard.
Although the extract does not include the later portions of the judgment, the reasoning shown demonstrates a consistent approach: the court demanded credible, corroborated evidence to rebut the statutory presumption and was unwilling to accept self-serving testimony or expert conclusions that depended on those same uncorroborated assertions. The court’s analysis also reflects the jurisprudential emphasis in Singapore drug cases on the accused’s ability to provide a coherent and evidentially supported explanation for how possession relates to personal consumption rather than trafficking.
What Was the Outcome?
Based on the extract, the court found that Selamat and Ali had not proved, on a balance of probabilities, that less than 15g (net) of diamorphine was intended for sale or that their possession was not for trafficking in excess of the threshold. The court therefore did not accept the defence’s attempt to rebut the s 17(c) presumption in the manner required to avoid the capital punishment threshold consequences.
The editorial note indicates that appeals from this decision were dismissed by the Court of Appeal on 5 March 2018 in Criminal Appeals Nos 33, 34 and 35 of 2016, reported as [2018] SGCA 13. This confirms that the High Court’s approach to the statutory presumption and the evaluation of the rebuttal evidence was upheld on appeal.
Why Does This Case Matter?
This case is significant for practitioners because it illustrates, in a concrete factual setting, how the statutory presumption of trafficking under s 17(c) operates and what the accused must do to rebut it. The decision underscores that rebutting the presumption is not a matter of raising a plausible doubt; it requires proof on a balance of probabilities. Where the defence relies on consumption rates and “intended sale” calculations, the court will scrutinise credibility, internal coherence, and whether the evidence is corroborated rather than self-referential.
For lawyers, the reasoning is particularly useful in understanding the limits of expert evidence in rebutting presumptions. The court rejected expert conclusions that were largely dependent on the accused’s uncorroborated statements. This is a practical reminder that expert reports in drug cases must be anchored in reliable inputs and must withstand cross-examination on methodology and assumptions. Similarly, the court’s treatment of withdrawal symptoms as a proxy for dosage demonstrates that general correlations may not be sufficient to establish specific consumption patterns relevant to trafficking thresholds.
Finally, the case highlights the evidential and logical scrutiny applied to “accounting” defences. Where the accused’s narrative implies they would sell at a loss, the court expects a credible explanation for how the accused nevertheless funded their drug use. The failure to explain mechanisms such as “rolling over the money” contributed to the court’s conclusion that the defence was not proved. In future cases, defence counsel should therefore consider whether their clients can provide corroborated evidence that aligns with both the statutory framework and the practical economics of drug transactions.
Legislation Referenced
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 5(1)(a)
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 12
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 17(c)
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 33(1)
Cases Cited
- [2018] SGCA 13 (Court of Appeal dismissal of appeals arising from this High Court decision)
- [2016] SGHC 226 (the present decision)
Source Documents
This article analyses [2016] SGHC 226 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.